| Felis catus |
Felis catus |
log(1/MED) |
2.432 |
None |
10.1021/jm00219a019 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
255000.0 |
nM |
10.1016/j.bmcl.2008.05.065 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
835000.0 |
nM |
10.1016/j.bmcl.2008.05.065 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1-acid glycoprotein 1 |
Activity |
9.0 |
uM |
10.1016/j.bmc.2007.04.060 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.02 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
0.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
D283 Med |
IC50 |
200000.0 |
nM |
10.1021/jm960592p |
| Homo sapiens |
D341 cell line |
IC50 |
200000.0 |
nM |
10.1021/jm960592p |
| Homo sapiens |
Daoy |
IC50 |
200000.0 |
nM |
10.1021/jm960592p |
| Homo sapiens |
Delta opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D5 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GABA-A receptor; anion channel |
IC50 |
106414301.82 |
nM |
10.1021/jm00004a017 |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
206.0 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
Absorption |
99.0 |
% |
10.1021/jm980527a |
| Homo sapiens |
Homo sapiens |
Activity |
0.99 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
FA |
99.0 |
% |
10.1021/jm000942e |
| Homo sapiens |
Homo sapiens |
FA |
99.0 |
None |
10.1021/jm001101a |
| Homo sapiens |
Homo sapiens |
Pc |
307000000.0 |
cm s-1 |
10.1021/jm001101a |
| Homo sapiens |
Homo sapiens |
Ratio |
1.0 |
None |
10.1021/jm001101a |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
9974.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1124/jpet.102.039255 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 6A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 5a (5-HT5a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serum albumin |
Activity |
17.0 |
uM |
10.1016/j.bmc.2007.04.060 |
| Homo sapiens |
SF-126 |
IC50 |
100000.0 |
nM |
10.1021/jm960592p |
| Homo sapiens |
SF-188 |
IC50 |
100000.0 |
nM |
10.1021/jm960592p |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Translocator protein |
IC50 |
106414301.82 |
nM |
10.1021/jm960536o |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
6.11 |
min |
10.1007/s00044-012-9977-1 |
| Mus musculus |
GABA-A receptor; anion channel |
IC50 |
9.4e-06 |
nM |
10.1021/jm00372a012 |
| Mus musculus |
GABA-A receptor; anion channel |
Ki |
73000.0 |
nM |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
Change |
35.0 |
% |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
Change |
48.0 |
% |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
Change |
70.0 |
% |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
Change |
nan |
None |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
ED50 |
0.28 |
mg.kg-1 |
10.1021/jm00372a012 |
| Mus musculus |
Mus musculus |
ED50 |
0.3 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
0.5 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
0.7 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
0.9 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
1.6 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
1.8 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
7.0 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
20.0 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
ED50 |
100.0 |
mg.kg-1 |
10.1021/jm00210a022 |
| Mus musculus |
Mus musculus |
log(1/ED50) |
0.557 |
None |
10.1021/jm00219a019 |
| Mus musculus |
Mus musculus |
log(1/ED50) |
1.654 |
None |
10.1021/jm00219a019 |
| Mus musculus |
Mus musculus |
log(1/MED) |
1.131 |
None |
10.1021/jm00219a019 |
| Mus musculus |
Mus musculus |
Log ED50 |
1.13 |
mM kg-1 |
10.1021/jm00362a003 |
| Mus musculus |
Mus musculus |
Permeability |
nan |
None |
10.1021/jm990968+ |
| Mus musculus |
Mus musculus |
TD50 |
11.86 |
mg kg-1 |
10.1021/jm00372a012 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
C6 |
IC50 |
200000.0 |
nM |
10.1021/jm960592p |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
49.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Peripheral-type benzodiazepine receptor |
IC50 |
520000.0 |
nM |
10.1021/jm960592p |
| Rattus norvegicus |
Rattus norvegicus |
Log 1/C |
0.832 |
None |
10.1021/jm00176a016 |
| Rattus norvegicus |
Rattus norvegicus |
Log 1/C |
1.247 |
None |
10.1021/jm00176a016 |
| Rattus norvegicus |
Rattus norvegicus |
Log 1/C |
1.83 |
None |
10.1021/jm00176a016 |
| Rattus norvegicus |
RG2 |
IC50 |
200000.0 |
nM |
10.1021/jm960592p |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
Activity |
99.0 |
% |
10.1021/jm048980b |
| None |
ADMET |
CC50 |
221000.0 |
nM |
10.1016/j.bmcl.2008.05.065 |
| None |
ADMET |
CL |
0.12 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
0.0 |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
F |
99.0 |
% |
None |
| None |
ADMET |
Fu |
0.03 |
None |
10.1021/jm030408h |
| None |
ADMET |
log10(%HIA +10) |
2.037 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
-Log C |
0.56 |
mM kg-1 |
10.1021/jm00178a018 |
| None |
ADMET |
-Log C |
0.65 |
mM kg-1 |
10.1021/jm00178a018 |
| None |
ADMET |
-Log C |
1.03 |
mM kg-1 |
10.1021/jm00178a018 |
| None |
ADMET |
-Log C |
1.13 |
mM kg-1 |
10.1021/jm00178a018 |
| None |
ADMET |
-Log C |
1.66 |
mM kg-1 |
10.1021/jm00178a018 |
| None |
ADMET |
MRT |
63.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Papp |
96000000.0 |
cm s-1 |
10.1021/jm001101a |
| None |
ADMET |
T1/2 |
46.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
50.0 |
hr |
10.1021/acs.jmedchem.0c00530 |
| None |
ADMET |
Vdss |
0.45 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.64 |
L.kg-1 |
10.1021/jm030408h |
| None |
NON-PROTEIN TARGET |
Fu |
0.03 |
None |
10.1124/dmd.108.020479 |
| None |
No relevant target |
log1/S0 |
4.23 |
None |
10.1016/j.ejmech.2007.04.009 |
| None |
No relevant target |
LogD |
2.93 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogP |
2.14 |
None |
10.1021/jm00176a016 |
| None |
No relevant target |
pKa |
nan |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKa |
nan |
None |
10.1021/jm030408h |
| None |
Unchecked |
Anti-fighting behaviour |
4.13 |
None |
10.1021/jm00171a037 |
| None |
Unchecked |
Anti-pent effect |
4.65 |
None |
10.1021/jm00171a037 |
| None |
Unchecked |
Clined screen test |
3.56 |
None |
10.1021/jm00171a037 |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Ratio CC50/IC50 |
1.0 |
None |
10.1016/j.bmcl.2008.05.065 |